NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Mesa Air Group, Inc. (NASDAQ: MESA) on behalf of Mesa stockholders. Our investigation concerns whether Mesa has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On or around August 9, 2018, Mesa conducted its initial public offering (“IPO”), selling approximately 9.63 million shares of common stock priced at $12.00. On May 10, 2019, the Company’s Chief Executive Officer (“CEO”) Jonathan Ornstein disclosed that beginning well in advance of the IPO, Mesa had been “hamstrung by the fact that we had expanded a lot . . . maintenance became more difficult in terms of qualified maintenance people.”
Then, on August 9, 2019, CEO Ornstein disclosed that Mesa had found it “very difficult to meet the performance criteria” under its contract with American Airlines Inc. and had ultimately failed to do so.
Since the IPO, Mesa’s stock price has traded as low as $2.32 per share, representing a decline of more than 80% from the Company’s offering price.
If you purchased or otherwise acquired Mesa shares and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato or Marion Passmore by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
